|
Volumn 25, Issue 9-11, 2006, Pages 1013-1017
|
Antitumor effects of 3,3′,4,4′,5,5′-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells
|
Author keywords
Apoptosis; Arabinofuranosylcytosine; Cell cycle; Polyhydroxylated stilbenes; Synergistic combination effects
|
Indexed keywords
3,3',4,4',5,5' HEXAHYDROXYSTILBENE;
PROPIDIUM IODIDE;
RESVERATROL;
STILBENE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CELL CYCLE ARREST;
CELL CYCLE G2 PHASE;
CELL CYCLE M PHASE;
CELL CYCLE S PHASE;
CELL STRAIN HL 60;
DRUG ACTIVITY;
FLOW CYTOMETRY;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
IC 50;
PROMYELOCYTIC LEUKEMIA;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BISBENZIMIDE;
CELL CYCLE;
CYTARABINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SCREENING ASSAYS, ANTITUMOR;
DRUG SYNERGISM;
FLUORESCENT DYES;
HL-60 CELLS;
HUMANS;
INHIBITORY CONCENTRATION 50;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
PROPIDIUM;
PYROGALLOL;
STILBENES;
|
EID: 33750460283
PISSN: 15257770
EISSN: 15322335
Source Type: Journal
DOI: 10.1080/15257770600890624 Document Type: Article |
Times cited : (14)
|
References (3)
|